Skip to main content

Table 4 Proportion of patients who may potentially avoid liver biopsy using the simple non-invasive tests to exclude advanced fibrosis.

From: Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

Fibrosis panel

Cut-off values

Patients avoiding liver biopsya

False negative result

FIB4 index

< 1.45

336/576 (58%)

6 (2%)

 

< 1.30

308/576 (53%)

4 (1%)

AST/ALT ratio (AAR)

< 0.8

413/576 (72%)

22 (5%)

AST to platelet ratio index (APRI)

< 1

435/576 (76%)

21 (5%)

Age-platelet index (AP index)

< 6

421/576 (73%)

22 (5%)

NAFLD fibrosis score

< -1.455

328/576 (57%)

5 (2%)

BARD score

< 2

355/576 (62%)

13 (4%)

N score

< 2

305/576 (53%)

13 (4%)

  1. aPatients with a value below the cut-off.